Physician profile
Stacey Hinkle
NPI 1851622237
$6,367.79
in general payments reported to CMS, 2019-2025
55 companies · $1,100 in 2025
The $1,100 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,036 · 2022: $1,144 · 2023: $1,507 · 2024: $1,582 · 2025: $1,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,143 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,143.34 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,468.08 | 2021-2025 | |
| Novo Nordisk INC | $859.08 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $463.96 | 2021-2025 | |
| Lilly USA, LLC | $366.34 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $268.15 | 2021-2025 | Repatha, Otezla, Prolia |
| Glaxosmithkline, LLC. | $242.10 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Xeris Pharmaceuticals, INC. | $220.43 | 2021-2025 | Gvoke Hypopen |
| Inari Medical, INC. | $184.90 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $174.78 | 2021-2025 | Xifaxan |
| Amarin Pharma, INC. | $160.36 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $151.57 | 2023-2025 | Rexulti |
| Astellas Pharma US INC | $99.14 | 2021-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.92 | 2021-2024 | Jardiance |
| Abbott Laboratories | $81.82 | 2022-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $78.22 | 2023-2025 | Dexcom G6 Transmitter |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Hinkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.